LOMBARDO, VALENTINA NUNZIELLA
 Distribuzione geografica
Continente #
NA - Nord America 240
AS - Asia 61
SA - Sud America 38
EU - Europa 32
Totale 371
Nazione #
US - Stati Uniti d'America 238
BR - Brasile 32
SG - Singapore 19
IT - Italia 18
HK - Hong Kong 15
VN - Vietnam 14
DE - Germania 8
CN - Cina 5
AR - Argentina 3
BD - Bangladesh 2
PY - Paraguay 2
RU - Federazione Russa 2
TR - Turchia 2
AT - Austria 1
BN - Brunei Darussalam 1
CL - Cile 1
FI - Finlandia 1
FR - Francia 1
ID - Indonesia 1
IN - India 1
IQ - Iraq 1
MX - Messico 1
PT - Portogallo 1
TT - Trinidad e Tobago 1
Totale 371
Città #
Dallas 217
Hong Kong 15
Ho Chi Minh City 6
The Dalles 6
Hanoi 4
Singapore 4
Los Angeles 3
Munich 3
Palermo 3
Asunción 2
Brooklyn 2
Catania 2
Milan 2
Rio de Janeiro 2
São Paulo 2
Thái Bình 2
Tremestieri Etneo 2
Ashburn 1
Bandar Seri Begawan 1
Barra do Corda 1
Buenos Aires 1
Cafelândia 1
Campinas 1
Campos Gerais 1
Casoria 1
Catalão 1
Contagem 1
Córdoba 1
Embu das Artes 1
Erbil 1
Fortaleza 1
Gaspar 1
Helsinki 1
Iguatu 1
Istanbul 1
Itaboraí 1
Itapemirim 1
Içara 1
Joinville 1
Juazeiro 1
Juazeiro do Norte 1
Khabarovsk 1
Kilis 1
Lisbon 1
Maceió 1
Manhuaçu 1
Mauá 1
Mexico City 1
Misilmeri 1
Montenegro 1
Mumbai 1
Muriaé 1
Natore 1
Nazário 1
New York 1
Ninh Bình 1
Novais 1
Nuremberg 1
Philadelphia 1
Porto Seguro 1
Quilicura 1
Rancho Alegre dOeste 1
Rondonópolis 1
Salgueiro 1
Salta 1
San Jose 1
San Juan 1
Santa Clara 1
Saratov 1
São José dos Campos 1
Totale 330
Nome #
Management of ocular toxicity in patients with gynecologic cancer receiving novel antibody–drug conjugates: a narrative review 218
Identification of the novel BRCA1 c.2463_2464delTA mutation in two high grade serous ovarian cancer sisters and potential dosage effects implications: a case report 47
Trabectedin maintenance therapy after liposomal doxorubicin plus trabectedin combination in patients with relapsed ovarian cancer: the randomized, phase II TRAMANT study 39
Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD Assessment 39
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 33
PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric survey 6
Totale 382
Categoria #
all - tutte 899
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 899


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202563 0 0 1 0 4 3 12 1 1 16 8 17
2025/2026319 14 19 230 32 19 5 0 0 0 0 0 0
Totale 382